课题基金 / 基金详情

Covid-19 Test Manager

Covid-19 Test Manager
Covid-19 测试经理
批准号:
62912
负责人:
金额:
$9.37万
依托单位国家:
英国
项目类别:
Feasibility Studies
财政年份:
2020
资助国家:
英国
项目状态:
已结题
起止时间:
2020 至 --
关键词:

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
我们的愿景是利用现有的产品School Screener Imms来(针对所有年龄段)提供大规模新冠肺炎测试的自动化、音频和可扩展的管理,包括患者反馈和结果分析。要解决的问题是:我们目前的基础设施是为特定路径的患者测试构建的,例如通过全科医生诊所测试胆固醇。在这种情况下,全科医生已经有了关于患者的信息,他们的需求,并具有反馈结果的机制。同样,在医院环境中,测试是为了特定目的而订购的,遵循患者的路径。不需要对每个人进行统一的测试,在这种情况下,需要收集相同的信息,在多个环境中以相同的方式,并以及时和统一的方式将结果传达给患者。我们目前基于患者路径的基础设施是不合适的,部分原因是它太复杂,部分原因是系统之间缺乏互操作性。此外,没有一个单一的系统是为在一个地区或大范围内扩展而设计的。汤姆森公司的Screener的School Screener IMMS产品拥有实现这一点的技术已经到位,但最终的改编和交付以适应该应用程序以适应大规模新冠肺炎自动化测试管理需要在该应用程序中额外的资金。该项目将有4个关键部分1。与NHS X和测试提供商合作,最终确定所需的功能2。建立和运行适应的测试系统,包括负载测试和扩展(6周)3.开发数据的KPI分析和运行方法4.调整应用程序并为向上扩展做好准备此解决方案的创新之处在于它调整了满足所有要求的现有系统。该解决方案是特定的,专注于需求,因此它可以快速实施。-其他信息-在成功完成对斯库尔斯纳IMMS模块的调整以管理新冠肺炎测试后,进行的试点揭示了人们管理测试的一个重要特征:必须提前预订。在秋季的几个月里,不仅对测试经理,而且对疫苗管理人员都出现了这种需求:能够同时预订测试和疫苗接种。一旦将其添加到测试管理器中,也将可用于疫苗接种管理。目前,该软件已经在学校管理流感疫苗接种,并增加了一个新的诊所和预约功能,它也将适用于管理Covid疫苗接种。交付内容是:测试和疫苗接种提供者创建诊所的能力,在每个诊所设置预约时段和容量。最终用户能够在他们的诊所预约提供者,并在必要时更改预约。目前,最终用户不可能更换提供者。如果时间允许,将包括允许最终用户更换供应商的可选开发。这没有完全计算成本,因此它可能不包括在最终交付中。
英文摘要
The vision is to utilise an existing product, SchoolScreener Imms to deliver (for all ages) automated, audible and scalable administration of large scale Covid-19 testing including patient feedback and outcome analytics.The problem to solve is this:Our current infrastructure is built for patient testing for specific pathways e.g testing cholesterol via a GP clinic. In this case the GP already has information about the patient, their needs and has the mechanism to feed the result back. Similarly in a hospital setting, a test is ordered for a specific purpose, following a patient pathways.There has not been a need for a uniform test for everybody, where the same information needs to be collected, the same way in multiple settings and the results communicated back to the patient in a timely and uniform manner. Our current infrastructure based on patient pathways is unsuitable, partly because it is too complex, partly due to lack of inter-operability between systems. Also, no single system is designed to scale across a region or large area.Thomson's Screening's SchoolScreener Imms product has the technology for this is already in place, but final adaptions and delivery to adapt the application for mass Covid-19 automated testing management requires the additional funding in this application.The project will have 4 key parts1. Work with NHS X and testing provider to finalise functionality required2. Build and operate the adapted testing system, including load testing and scaling (6weeks)3. Develop KPI analysis of data and methodology for operating4. Adapt the application and prepare for scaling upThe innovation in this solution is in its adapting an existing system that meets all requirements.The solution is specific and focused to the need and therefore it is quick to implement.-ADDITIONAL INFORMATION-Following the successful completion of adaptation of the Schoolscreener Imms module to manager Covid-19 Testing, the pilot conducted revealed an important feature of how people manage testing: pre-booking is necessary.During the autumn months this need has emerged not just for the test manager but also vaccination management: the ability to make bookings for both testing and vaccination. Once this is added to the Test Manager also will also be available for vaccination management. Currently the software already manages Flu vaccinations in schools and with adding a new Clinic and Booking feature it will also be suitable for managing Covid vaccinations.The deliverables are:Ability for testing and vaccination providers to create clinics, set appointment slots and capacity in each clinic.Ability for end user to book an appointment with a provider, in their clinic and if necessary change that appointment.Currently it is not possible for an end-user to change provider. If time allows, an optional development will be included that allows an end user to change provider. This is not fully costed, so it may not be included in the the final delivery.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
芽孢杆菌TR19-1对魔芋腐皮镰刀菌拮抗机理研究
1H/19F多核MRI术中可视化免疫抑制巨噬细胞定位脑胶质瘤浸润边界
ATPIF1调节线粒体膜电位影响靶向CD19 CAR-T细胞抗肿瘤活性的作用及机制
  • 批准号:
    2026JJ80001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    钟根深
  • 依托单位:
CD19/BCMA双靶向CAR-NK细胞治疗难治性SLE:作用机制与临床前转化研究
  • 批准号:
    2026JJ81339
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    谢希
  • 依托单位: